MEMPHASYS LIMITED. — Capital/Financing Update 2013

Mar 14, 2013

==> picture [196 x 96] intentionally omitted <==

FOR IMMEDIATE RELEASE

NuSep completes divestiture of non-Core ProteoIQ software

Sydney, Australia 15[th] March 2013– NuSep (ASX:NSP) wishes to update the market on its previous announcement on 24[th] January 2013 that NuSep had received an unsolicited offer to acquire its ProteoIQ software, which is a non-core asset of the Company.

The Company has now completed the sale of this software to PREMIER Biosoft and the ProteoIQ software will now be sold by PREMIER Biosoft.

The significance of this transaction is not the quantum of the sale price, which is not a material amount after expenses, but rather the refocusing of NuSep’s business on the PrIME Technology. The ProteoIQ software had been fully written off in a prior financial period and in the last six months ended 31 December 2012 only generated sales of $105,591.

ENDS

For more information please contact:

Contact: Prakash Patel NuSep +61 2 8415 7300 prakash.patel@nusep.com

Shonali Paul PREMIER Biosoft +650 856 2703 shonali@premierbiosoft.com

About NuSep

NuSep (ASX: NSP) is a publicly listed life sciences company that sells products into the global BioSeparations market. The company has offices in both Sydney Australia and Atlanta, USA.

With a 30 year heritage in biological separations, NuSep has forged a world class reputation for its innovative yet simple biological separation techniques based on the PrIME[1] technology. This PrIME technology has produced a number of world firsts including the world’s first IVF sperm separation instrument. In short NuSep has redefined the BioSeparations market through innovation and simplification.

1 PrIME stands for Pr eparative I solation by M embrane E lectrophoresis

NuSep Holdings Ltd 324 Burns Bay Rd Lane Cove NSW 2066

Postal Address Contact Details Email info@nusep.com P.O. Box 823 Telephone +61 2 8415 7300 Web www.nusep.com Lane Cove NSW 1595 Facsimile +61 2 8415 7399 ABN 33 120 047 556

– 2 –

NuSep’s world renowned research team has developed an extensive portfolio of patented products. In all, NuSep currently manufactures, distributes and sells 55 products to customers in the USA, Europe, Asia and Australia.

NuSep Products:

==> picture [12 x 17] intentionally omitted <==

• Gels – NuSep manufactures and sells precast gels including the innovative nUView Gels, which can be visualised 2 minutes after use.

==> picture [12 x 17] intentionally omitted <==

• Separation Instruments – NuSep has developed two unique biological separation instruments. The ProteomeSep was released in 2009 and can separate biological samples into 8 fractions for use in the proteomic market. The SpermSep separates sperm for fertility treatments such as IVF.

==> picture [12 x 17] intentionally omitted <==

• Biological Products – NuSep supplies research grade biological products manufactured using its unique separation technologies. These products include human IgG and Albumin.

For more information about NuSep please visit the company’s website www.NuSep.com

About PrIME Biologics Pte Ltd

PrIME Biologics is a Singapore based biotech company that has developed a disposable therapeutic plasma manufacturing process based on NuSep’s PrIME Technology. NuSep has a 90% shareholding in PrIME Biologics. PrIME Biologics process is based on the Pr eparative I solation by M embrane E lectrophoresis (PrIME) technology developed by NuSep. PrIME provides disposable modular processing that is ‘electronically’ driven membrane fractionation.

The PrIME process increases product yields to over 90% relative to the existing process 50% while increasing product safety. The PrIME has been shown to remove virus, bacteria, endotoxins and prions which cause ‘Mad Cow Disease’. Further, PrIME Biologics process can produce multiple plasma products in hours compared to days, which is required by the current manufacturers.

The initial application for the PrIME process will be the Currently Unprocessable Plasma which represents approximately 50% of all the plasma collected in many Asian countries.

About PREMIER Biosoft

Based in Palo Alto, California, PREMIER Biosoft was founded in 1994. The company is led by computer scientists and biologists dedicated to producing cutting-edge intuitive software for research in life sciences. The company's goal is to study the most recent innovations in life sciences and translate them into software products to aid research. Follow PREMIER Biosoft on Twitter @PREMIERBiosoft and on Facebook.

For more information about PREMIER Biosoft please visit the company’s website www.premierbiosoft.com